ID: ALA3949239

Max Phase: Preclinical

Molecular Formula: C30H35F3N8O3

Molecular Weight: 612.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCC[C@H]1C(=O)N1CCC(CCOc2ncc(-c3nc(C#N)nc4c3ncn4CC3CCOC3)cc2C(F)(F)F)CC1

Standard InChI:  InChI=1S/C30H35F3N8O3/c1-39-8-2-3-23(39)29(42)40-9-4-19(5-10-40)7-12-44-28-22(30(31,32)33)13-21(15-35-28)25-26-27(38-24(14-34)37-25)41(18-36-26)16-20-6-11-43-17-20/h13,15,18-20,23H,2-12,16-17H2,1H3/t20?,23-/m0/s1

Standard InChI Key:  RYCOMPBHWFLWCG-AKRCKQFNSA-N

Associated Targets(Human)

CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ctss Cathepsin S (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 612.66Molecular Weight (Monoisotopic): 612.2784AlogP: 3.92#Rotatable Bonds: 8
Polar Surface Area: 122.29Molecular Species: NEUTRALHBA: 10HBD: 0
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.10CX LogP: 3.13CX LogD: 2.35
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.37Np Likeness Score: -0.92

References

1.  (2016)  Nitrogen-containing bicyclic aromatic heterocyclic compound, 

Source

Source(1):